Labs / Assays & in vitro testing
A28 Therapeutics
La Jolla, CA, United States · a28therapeutics.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
A28 Therapeutics is a clinical-stage biopharmaceutical company focused on developing targeted oncolytic peptides for the treatment of multiple cancer types. It is based in La Jolla, California, and its lead compound AT-101 is being developed for metastatic ovarian cancer with liver metastases, hepatocellular carcinoma, and other solid tumors with liver metastases.
Their website has a general contact form; we send your quote request through it.
What they offer
Targeted oncolytic peptide platform development
Develops a TOP platform based on conjugates of the CLYP-71 oncolytic peptide and targeting units for cancer treatment.
AT-101 development
Advances AT-101 as a lead targeted oncolytic peptide candidate in late-stage clinical development.
Combination therapy development
Studies AT-101 in combination with immuno-oncology therapeutics, checkpoint inhibitors, PARP inhibitors, and chemotherapy.
What they work on
- Modalities
- Antibody, Peptide, Cell therapy
- Scale and capacity
- production scaled to Kg levels
- Therapeutic areas
- cancer, metastatic ovarian cancer with liver metastases, hepatocellular carcinoma, solid tumors with liver metastases, hematological malignancies
- Sites
- La Jolla, United States
- Serves
- worldwide
- Address
- 7660 Fay Ave H-829 La Jolla, CA 92037
- Founded
- 2021
Similar labs. Avantia Labs, Oncodesign Services, 3C Therapeutics, Abeomics
Found in a contract services directory. Listing built from a28therapeutics.com. Work here? Claim this listing.